A new company launched by Google will seek to extend human life spans.
Antonio RegaladoFollow @twitterapi
Senior Editor, Business
I am the business editor of MIT Technology Review. I look for stories about how technology is changing business. Before joining MIT Technology Review in July 2011, I lived in São Paulo, Brazil, where I wrote about science, technology, and politics in Latin America for Science and other publications. From 2000 to 2009, I was the science reporter at the Wall Street Journal and later a foreign correspondent.
Antonio Regalado's Stories
Reading the DNA of fetuses is the next frontier of the genome revolution. Do you really want to know the genetic destiny of your unborn child?
Putting genome data into the public domain advances science, but nearly all of it can be linked to someone.
By reviving lost species, a new company could put a warm and fuzzy face on advanced reproductive engineering.
Advances in genetic engineering have some biologists convinced they’ll re-create extinct species.
An ultrathin electrode spun from a single carbon fiber can record neurons in living animals.
J. Craig Venter may have just started a race to discover alien life on the Red Planet.
Kari Stefansson says his genetic research company has shown that older fathers pass many more DNA mutations to their children.
A study of whether embryonic stem cells could cure spinal-cord injury suffered from high costs, dim prospects.
A small biotech firm is the second company to start human tests of embryonic stem-cell therapy.